Centre for Drug Research and Development-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Centre for Drug Research and Development - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014163
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Centre for Drug Research and Development (CDRD) is a drug development and commercialization center that provides infrastructure to transform basic health research in academic institutions and early-stage therapeutic technologies into new medicines. The center offers target validation, screening, drug delivery, medicinal chemistry, pharmacology and toxicology, biologics and external platforms. It spans its expertise in the therapeutic areas of neuroscience, oncology, inflammation, fibrosis and others. CDRD’s target validation programs comprise vivo efficacy model development, assay development and transfer, and others. The center has also established national, provincial, and international partnerships, and developed specially-trained highly-qualified personnel. CDRD is headquartered in Vancouver, British Columbia, Canada.

Centre for Drug Research and Development – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Centre for Drug Research and Development, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Centre for Drug Research and Development, Medical Devices Deals, 2011 to YTD 2017 9
Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Zucara Therapeutics Raises USD0.4 Million in Venture Financing 12
Partnerships 13
Aequus Pharma and Centre for Drug Research and Development Enter into a Research Agreement 13
Novelogics Biotech Enters into Research Agreement with Centre for Drug Research and Development 14
Centre for Drug Research and Development Partners with AstraZeneca 15
Centre for Drug Research and Development Enters into Agreement with viDA Therapeutics 16
The Centre For Drug Research Enters Into Co-Development Agreement With F. Hoffmann-La Roche 17
CDRD Enters Into Preferred Collaboration With National Research Council 18
CDRD Enters Into An Agreement With Lead Discovery Center 19
CDRD Enters Into Co-Development Agreement With PANAMP 20
CDRD Enters Into Co-Development Agreement With NGDI-UBC 21
Licensing Agreements 22
Zucara Therapeutics Enters into Licensing Agreement with Centre for Drug Research and Development 22
Centre for Drug Research and Development – Key Competitors 23
Centre for Drug Research and Development – Key Employees 24
Centre for Drug Research and Development – Locations And Subsidiaries 25
Head Office 25
Recent Developments 26
Corporate Communications 26
May 01, 2017: CDRD appoints CFO 26
May 01, 2017: CDRD Appoints Matthew J. Carlyle Chief Financial Officer 27
Feb 01, 2017: CDRD Appoints Gordon McCauley as President and CEO 28
Sep 09, 2016: Zucara Therapeutics appoints Michael Midmer as CEO 29
Government and Public Interest 30
Mar 09, 2017: Stem Cell & Regenerative Medicine Leaders Join Forces to Advance Canada’s Position in the Field 30
Nov 23, 2016: Transforming drug research and development in B.C. 31
Product News 32
Jun 27, 2017: LifeArc, Dstl and CDRD Collaborate to Identify Antibacterial Drug Targets 32
Other Significant Developments 33
Jun 08, 2016: CDRD Collaborator ImStar Therapeutics Receives Investment by Accel-Rx 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Key Facts 2
Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Centre for Drug Research and Development, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Centre for Drug Research and Development, Deals By Therapy Area, 2011 to YTD 2017 8
Centre for Drug Research and Development, Medical Devices Deals, 2011 to YTD 2017 9
Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Zucara Therapeutics Raises USD0.4 Million in Venture Financing 12
Aequus Pharma and Centre for Drug Research and Development Enter into a Research Agreement 13
Novelogics Biotech Enters into Research Agreement with Centre for Drug Research and Development 14
Centre for Drug Research and Development Partners with AstraZeneca 15
Centre for Drug Research and Development Enters into Agreement with viDA Therapeutics 16
The Centre For Drug Research Enters Into Co-Development Agreement With F. Hoffmann-La Roche 17
CDRD Enters Into Preferred Collaboration With National Research Council 18
CDRD Enters Into An Agreement With Lead Discovery Center 19
CDRD Enters Into Co-Development Agreement With PANAMP 20
CDRD Enters Into Co-Development Agreement With NGDI-UBC 21
Zucara Therapeutics Enters into Licensing Agreement with Centre for Drug Research and Development 22
Centre for Drug Research and Development, Key Competitors 23
Centre for Drug Research and Development, Key Employees 24

★海外企業調査レポート[Centre for Drug Research and Development-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Future Retail Limited (FRL):企業の財務・戦略的SWOT分析
    Future Retail Limited (FRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • The Hershey Co:戦略・SWOT・企業財務分析
    The Hershey Co - Strategy, SWOT and Corporate Finance Report Summary The Hershey Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • The Indian Hotels Company Limited:企業の戦略・SWOT・財務情報
    The Indian Hotels Company Limited - Strategy, SWOT and Corporate Finance Report Summary The Indian Hotels Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Sultan Center Food Products Co. KSC (SULTAN):企業の財務・戦略的SWOT分析
    Sultan Center Food Products Co. KSC (SULTAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Outlook Therapeutics Inc (ONSIU):企業の財務・戦略的SWOT分析
    Summary Outlook Therapeutics Inc (Outlook Therapeutics), formerly Oncobiologics Inc, is a biopharmaceutical company that develops, manufactures and commercializes biosimilar products in the areas of ophthalmology. The company is investigating its lead product candidate, ONS-5010 an ophthalmic formul …
  • Abivax SA (ABVX)-製薬・医療分野:企業M&A・提携分析
    Summary Abivax SA (Abivax) is a biotechnology company that researches, develops and commercializes anti-viral therapies and therapeutic vaccines for the treatment of infectious diseases. The company’s pipeline products comprise ABX464, a small molecule against HIV; ABX311 for chikungunya; ABX544 to …
  • Mr. Price Group Ltd.:企業の戦略・SWOT・財務分析
    Mr. Price Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mr. Price Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • California Pizza Kitchen, Inc.:企業の戦略的SWOT分析
    California Pizza Kitchen, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Osaka Gas Co Ltd (9532):石油・ガス:M&Aディール及び事業提携情報
    Summary Osaka Gas Co Ltd (OGCL) supplies natural gas to its customers in Kansai region, besides offering LPG, electricity and other energy-related products and services through affiliated enterprises. Its operations consist of domestic energy, environmental and non-energy, and international energy b …
  • MedMira Inc (MIR):企業の財務・戦略的SWOT分析
    Summary MedMira Inc (MedMira) is a developer, manufacturer and marketer of rapid diagnostics and technology platforms. The company offers products in the areas of HIV, H. pylori, multiplex, syphilis, miriad rvf toolkit, and tissue and eye banks. MedMira offers Miriad RVF toolkit that facilitates the …
  • Tieto Corp (TIETO):企業の財務・戦略的SWOT分析
    Tieto Corp (TIETO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Aralez Pharmaceuticals Inc (ARLZ):製薬・医療:M&Aディール及び事業提携情報
    Summary Aralez Pharmaceuticals Inc (Aralez Pharma) is a pharmaceutical company that develops and commercializes therapeutic drugs. The company offers products in the fields of cardiovascular diseases, pain management, dermatology, gastrointestinal, and other areas. Its pain management products inclu …
  • Augmenix Inc-医療機器分野:企業M&A・提携分析
    Summary Augmenix Inc (Augmenix) is a medical device company that develops space-filling hydrogels for radiation oncology and cancer surgery indications. The company offers products such as hydrogel products, space OAR systems, absorbable tissue marker, and trace-IT hydrogel products. Its TraceIT hyd …
  • NuVista Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    NuVista Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary NuVista Energy Ltd (NuVista) is an oil and gas company that offers exploration, development and production of oil and natural gas reserves. The company conducts its operations in Western Canadian …
  • Orexo AB (ORX):企業の財務・戦略的SWOT分析
    Orexo AB (ORX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Sinclair Broadcast Group, Inc.:企業の戦略・SWOT・財務分析
    Sinclair Broadcast Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Sinclair Broadcast Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • ConforMIS Inc (CFMS):企業の財務・戦略的SWOT分析
    Summary ConforMIS Inc (ConforMIS) is a medical technology company that manufactures, develops, and markets joint replacement implants. The company’s knee replacement implant products include iTotal CR a cruciate-retaining product, iTotal PS a posterior cruciate ligament substituting product, and iDu …
  • Shinva Medical Instrument Co Ltd (600587):医療機器:M&Aディール及び事業提携情報
    Summary Shinva Medical Instrument Co., Ltd. (Shinva Medical) manufactures and markets medical instruments and environmental protection equipment for various healthcare markets. The company’s product portfolio includes sterilizers, radiotherapy equipment, digital diagnosis equipment, surgical instrum …
  • Serodus ASA:製薬・医療:M&Aディール及び事業提携情報
    Summary Serodus ASA (Serodus) is a drug development company that develops treatments for unmet clinical needs in the areas of diabetes and diabetic comorbidities. The company’s pipeline products include SER150DN, an anti-inflammatory compound under development for diabetic nephropathy; SER130AMI, an …
  • Garden Fresh Restaurants, LLC:企業の戦略・SWOT・財務分析
    Garden Fresh Restaurants, LLC - Strategy, SWOT and Corporate Finance Report Summary Garden Fresh Restaurants, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆